AF solution
Oncology
Immuno Oncology
Anti-Virus
Disease Modeling
Cosmetics
Toxicity
Spatial Biology
Technology Service
Cancer Organoid
Research Service
Others
Transform your research and innovation landscape with our CRISPR-Cas9 gene editing services.
As a leader in genomic engineering, we offer tailored solutions that enable precise modifications at the DNA level, facilitating groundbreaking advancements in genetics, agriculture, and medicine.
Our team of experts utilizes the latest CRISPR-Cas9 technology to ensure accurate and efficient gene editing, making even the most complex genetic modifications achievable.
Whether you’re developing new therapies, enhancing crop resilience, or studying gene functions, our services are customized to meet your specific research needs.
We adhere to the highest standards of ethical practices and regulatory compliance, ensuring that all modifications are safe, ethical, and legally sound.
Leverage our streamlined CRISPR workflows to accelerate your projects from concept to reality, significantly reducing development times and speeding up your route to discovery.
Partner with us to push the boundaries of what’s possible in genetic research. Our cutting-edge technology and comprehensive support will empower your endeavors, enabling more precise, efficient, and transformative outcomes.
Unlock the potential of cellular therapy and regenerative medicine with our iPSC Generation Service.
Our service offers cutting-edge induced pluripotent stem cell (iPSC) technology to transform adult cells into pluripotent stem cells, providing a scalable and ethical source of patient-specific cells for research, therapy, and drug development.
Utilize our state-of-the-art methods to efficiently convert adult cells into high-quality iPSCs, which are capable of differentiating into various cell types.
Tailor our service to meet your specific project needs, whether you are conducting basic research, disease modeling, or developing personalized therapies.
Avoid ethical concerns associated with embryonic stem cells by using iPSCs derived from adult cells, ensuring a responsible approach to biomedical research.
Accelerate your research and clinical applications with our reliable supply of customizable iPSCs, streamlining the path from bench to bedside.
Partner with us to leverage the transformative potential of iPSCs. Our expertise in cellular reprogramming aids in advancing your research in cellular therapies, drug testing, and disease modeling, contributing to significant breakthroughs in medicine.
Enhance your genetic research and therapeutic development with our Viral Vector Cloning Service.
Our service provides tailored viral vector design and cloning techniques to facilitate efficient gene delivery for various applications, including gene therapy, vaccine development, and basic research.
Work with our team of experts to design and construct viral vectors that are optimized for specific delivery needs and target cell types.
Our advanced cloning techniques ensure high viral titer and specific targeting, improving the efficacy and safety of your gene delivery projects.
Choose from a variety of vector backbones, including lentivirus, adenovirus, and adeno-associated virus (AAV), to suit your specific research and therapeutic needs.
Our viral vectors are produced in compliance with current regulatory standards, ensuring safety and efficacy for clinical applications.
Partner with us to utilize cutting-edge viral vector technologies that drive innovation and precision in gene therapy and related fields. Our tailored solutions streamline the development process, from vector design to production, empowering your projects with the best in gene delivery technology.
Unlock the full potential of genetic research with the advanced Next-Generation Sequencing (NGS) services offered.
Our state-of-the-art NGS platforms provide comprehensive and detailed insights into the genome, transcriptome, and epigenome, facilitating groundbreaking discoveries in genetics, personalized medicine, and disease research.
Benefit from our high-throughput sequencing technology that offers rapid and accurate analysis of large-scale genomic data.
Tailor your sequencing project with a wide range of sequencing options, including whole-genome sequencing, targeted resequencing, RNA-seq, and more, to meet your specific research needs.
Utilize our sophisticated bioinformatics tools to interpret complex data, transforming raw sequences into actionable insights.
Collaborate with our team of experts who provide support throughout the sequencing process, from sample preparation to data analysis.
Partner with us to push the boundaries of what’s possible in genetic research. Our NGS services are designed to streamline your research process, enhancing the speed and accuracy of your findings and helping you make significant advancements in your field.
Delve deeper into cellular complexity with our Single-Cell RNA Sequencing services.
Our state-of-the-art scRNA-seq technology dissects individual cell profiles, revealing gene expression patterns at a resolution never before possible. This powerful tool is crucial for advancing research in developmental biology, oncology, immunology, and beyond.
Capture the transcriptomic details of individual cells, uncovering novel cell types and molecular pathways that are critical for understanding complex biological processes.
Our advanced bioinformatics pipelines interpret vast amounts of data, providing you with a detailed map of cellular diversity and gene expression dynamics.
Whether you’re exploring tumor heterogeneity or mapping the development of different cell lineages, our service is customized to fit your specific research goals.
From sample preparation to data analysis, our expert team guides you through the entire scRNA-seq process, ensuring quality and reliability at every step.
With our scRNA-seq services, gain the insights needed to propel your research into new realms. This service empowers you to make groundbreaking discoveries in disease mechanisms, response to therapy, and cellular function.
@ 2024 . All rights reserved
@ 2024 . All rights reserved